Gfi1-cells and circuits: Unraveling transcriptional networks of development and disease

Current Opinion in Hematology

Volumn 17, Issue 4, 2010, Pages 300-307

  Phelan, James D ^a,b   Shroyer, Noah F ^c   Cook, Tiffany ^d   Gebelein, Brian ^d   Grimes, H Leighton ^b,e  

^a Immunobiology Graduate Program   (United States)

^b Division of Immunobiology   (United States)

^c Division of Gastroenterology   (United States)

^d Division of Developmental Biology   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

growth factor independent 1; hematopoiesis; HoxA9; leukemia; Pu.1; severe congenital neutropenia; transcription

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR INDEPENDENT 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GFI1 PROTEIN, HUMAN;

AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DYSREGULATION; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOCYTE; LYMPHOID CELL; LYMPHOPOIESIS; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; GENE REGULATORY NETWORK; GENETICS; HEMATOPOIESIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DNA-BINDING PROTEINS; GENE REGULATORY NETWORKS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; NEUTROPENIA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 77954071946     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833a06f8     Document Type: Review

References (79)

1. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 1993; 13:1759-1768.
2. Scheijen B, Jonkers J, Acton D, Berns A. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J Virol 1997; 71:9-16.
3. Uren AG, Kool J, Matentzoglu K, etal. Large-scale mutagenesis in p1 9(ARF)-and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 2008; 133:727-741.
4. Horman SR, Velu CS, Chaubey A, et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 2009; 113:5466-5475.
5. Kazanjian A, Gross EA, Grimes HL. The growth factor independence-1 transcription factor: new functions and new insights. Crit Rev Oncol Hematol 2006; 59:85-97.
6. Boztug K, Klein C. Novel genetic etiologies of severe congenital neutropenia. Curr Opin Immunol 2009; 21:472-480.
7. Moroy T, Zeng H, Jin J, et al. The zinc finger protein and transcriptional repressor Gfi1 as a regulator of the innate immune response. Immunobiology 2008; 213:341-352.
8. Shroyer NF, Wallis D, Venken KJ, etal. Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. Genes Dev 2005; 19:2412-2417.
9. Kazanjian A, Wallis D, Au N, et al. Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Res 2004; 64:6874-6882.
10. Wallis D, Hamblen M, Zhou Y, et al. The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival. Development 2003; 130:221-232.
11. Grimes HL, Chan TO, Zweidler-McKay PA, et al. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol 1996; 16:6263-6272.
12. McGhee L, Bryan J, Elliott L, et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J Cell Biochem 2003; 89:1005-1018.
13. Duan Z, Zarebski A, Montoya-Durango D, et al. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol Cell Biol 2005; 25:10338-10351.
14. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007; 27:562-572.
15. Montoya-Durango DE, Velu CS, Kazanjian A, et al. Ajuba functions as a histone deacetylase-dependent co-repressorfor autoregulation of the growth factor-independent-1 transcription factor. J Biol Chem 2008; 283:32056-32065.
16. Spooner CJ, Cheng JX, Pujadas E, et al. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 2009; 31:576-586.
17. Khanna-Gupta A, Sun H, ZibelloT, etal. Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPepsilon gene. Blood 2007; 109:4181-4190.
18. Zeng H, Yucel R, Kosan C, et al. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 2004; 23: 4116-4125.
19. Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004; 431:1002-1007.
20. Tong B, Grimes HL, Yang TY, et al. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol 1998; 18:2462-2473.
21. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804-1808.
22. van Os R, de Haan G, Dykstra BJ. Hematopoietic stem cell quiescence: yet another role for p53. Cell Stem Cell 2009; 4:7-8.
23. Foudi A, Hochedlinger K, Van Buren D, et al. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol 2009; 27:84-90.
24. Liu Y, Elf SE, Miyata Y, et al. p53 regulates hematopoietic stem cell quies-cence. Cell Stem Cell 2009; 4:37-48.
25. Lacorazza HD, Yamada T, Liu Y, et al. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell 2006; 9:175-187.
26. Shounan Y, Dolnikov A, MacKenzie KL, et al. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia 1996; 10:1619-1628.
27. TeKippe M, Harrison DE, Chen J. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp Hematol 2003; 31:521-527.
28. Kuo YH, Zaidi SK, Gornostaeva S, et al. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice. Blood 2009; 113:3323-3332.
29. Huh HJ, Chae SL, Lee M, et al. CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome. Int J Lab Hematol 2009; 31:344-351.
30. Boxer LA. Severe congenital neutropenia: genetics and pathogenesis. Trans Am Clin Climatol Assoc 2006; 117:13-31; discussion 31-32.
31. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96:2317-2322.
32. Ancliff PJ, Gale RE, Liesner R, et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98:2645-2650.
33. Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001; 27:313-317.
34. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39:86-92.
35. Dror Y, Ward AC, Touw IP, Freedman MH. Combined corticosteroid/ granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: activated glucocorticoid receptors synergize with G-CSF signals. Exp Hematol 2000; 28:1381-1389.
36. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003; 34:308-312.
37. Xia J, Bolyard AA, Rodger E, et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutro penia. Br J Haematol 2009; 147:535-542.
38. Zarebski A, Velu CS, Baktula AM, et al. Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. Immunity 2008; 28:370-380.
39. Dahl R, Walsh JC, Lancki D, etal. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat Immunol 2003; 4:1029-1036.
40. Laslo P, Spooner CJ, Warmflash A, etal. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006; 126:755-766.
41. Zhuang D, Qiu Y, Kogan SC, Dong F. Increased CCAAT enhancer-binding protein epsilon (C/EBPepsilon) expression and premature apoptosis in myeloid cells expressing Gfi-1 N382S mutant associated with severe congenital neutropenia. J Biol Chem 2006; 281:10745-10751.
42. Velu CS, Baktula AM, Grimes HL. Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood 2009; 113:4720-4728.
43. Salipante SJ, Rojas ME, Korkmaz B, et al. Contributions to neutropenia from PFAAP5 (N4BP2L2), a novel protein mediating transcriptional repressor cooperation between Gfi1 and neutrophil elastase. Mol Cell Biol 2009; 29:4394-4405.
44. Hu YL, Passegue E, Fong S, et al. Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood 2007; 109:4732-4738.
45. Hess JL, Bittner CB, Zeisig DT, et al. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 2006; 108:297-304.
46. Morgado E, Albouhair S, Lavau C. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation. Blood 2007; 109:4020-4022.
47. Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood 2005; 106:254-264.
48. Li-Kroeger D, Witt LM, Grimes HL, et al. Hox and senseless antagonism functions as a molecular switch to regulate EGF secretion in the Drosophila PNS. Dev Cell 2008; 15:298-308.
49. Khandanpour C, Thiede C, Valk PJ, et al. A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia. Blood 2010; 115:2462-2472.
50. Hochberg JC, Miron PM, Hay BN, etal. Mosaictetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia. Pediatr Blood Cancer 2008; 50:630-632.
51. De La Luz Sierra M, Gasperini P, McCormick PJ, et al. Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells. Blood 2007; 110:2276-2285.
52. Yucel R, Karsunky H, Klein-Hitpass L, Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med 2003; 197: 831-844.
53. Park JH, Yu Q, Erman B, etal. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004; 21:289-302.
54. Pargmann D, Yucel R, Kosan C, etal. Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function. Eur J Immunol 2007; 37:3551-3563.
55. Zhu J, Guo L, Min B, et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 2002; 16:733-744.
56. Watkins NA, Gusnanto A, de Bono B, et al. AHaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 2009; 113:e1-9.
57. Shinnakasu R, Yamashita M, Kuwahara M, etal. Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation. J Biol Chem 2008; 283:28216-28225.
58. Zhu J, Davidson TS, Wei G, etal. Down-regulation of Gfi-1 expression byTGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 2009; 206:329-341.
59. Ichiyama K, Hashimoto M, Sekiya T, et al. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity. Int Immunol 2009; 21:881-889.
60. Suffia IJ, Reckling SK, Piccirillo CA, et al. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 2006; 203:777-788.
61. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 2005; 174:5444-5455.
62. Alcina A, Fernandez O, Gonzalez JR, et al. Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis. Eur J Hum Genet.
63. Chandele A, Joshi NS, Zhu J, et al. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J Immunol 2008; 180:5309-5319.
64. Rathinam C, Klein C. Transcriptional repressor Gfi1 integrates cytokine-receptor signals controlling B-cell differentiation. PLoS One 2007; 2:e306.
65. Dahl R, Iyer SR, Owens KS, et al. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction. J Biol Chem 2007; 282:6473-6483.
66. Glynne R, Ghandour G, Rayner J, et al. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol Rev 2000; 176:216-246.
67. Rathinam C, Lassmann H, Mengel M, Klein C. Transcription factor Gfi1 restricts B cell-mediated autoimmunity. J Immunol 2008; 181:6222-6229.
68. Igwe E, Kosan C, Khandanpour C, et al. The zinc finger protein Gfi1 is implicated in the regulation of IgG2b production and the expression of Igamma2b germline transcripts. Eur J Immunol 2008; 38:3004-3014.
69. Dabrowska MJ, Dybkaer K, Johnsen HE, etal. Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. J Virol 2009; 83:8051-8061.
70. Zornig M, Schmidt T, Karsunky H, et al. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene 1996; 12:1789-1801.
71. Marteijn JA, van der Meer LT, van Emst L, et al. Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1. Blood 2007; 110:3128-3135.
72. Marteijn JA, van der Meer LT, Van Emst L, et al. Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes. Blood 2007; 109:100-108.
73. Basu S, Liu Q, Qiu Y, Dong F. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci USA 2009; 106:1433-1438.
74. Acar M, Jafar-Nejad H, Giagtzoglou N, et al. Senseless physically interacts with proneural proteins and functions as a transcriptional co-activator. Development 2006; 133:1979-1989.
75. Powell LM, Deaton AM, Wear MA, Jarman AP. Specificity of Atonal and Scute bHLH factors: analysis of cognate E box binding sites and the influence of Senseless. Genes Cells 2008; 13:915-929.
76. Xie B, Charlton-Perkins M, McDonald E, et al. Senseless functions as a molecular switch for color photoreceptor differentiation in Drosophila. Development 2007; 134:4243-4253.
77. Yang Z, Ding K, Pan L, etal. Math5 determines the competence state of retinal ganglion cell progenitors. Dev Biol 2003; 264:240-254.
78. Tsuda H, Jafar-Nejad H, Patel AJ, et al. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell 2005; 122:633-644.
79. Jafar-Nejad H, Acar M, Nolo R, etal. Senseless acts as a binary switch during sensory organ precursor selection. Genes Dev 2003; 17:2966-2978.